NEO-B12 Injection Hydroxocobalamin 1000 microgram/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

neo-b12 injection hydroxocobalamin 1000 microgram/1 ml injection ampoule

pfizer australia pty ltd - hydroxocobalamin chloride, quantity: 1.027 mg - injection, solution - excipient ingredients: water for injections; acetic acid; sodium chloride - the approved indications for hydroxocobalamin injection are for prophylaxis and treatment of pernicious (addisonian) anaemia and other macrocytic anaemias associated with vitamin b12 deficiency. treatment of optic neuropathies such as tobacco amblyopia and leber's optic atrophy.

DBL AMINOPHYLLINE 250mg/10mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

dbl aminophylline 250mg/10ml injection ampoule

pfizer australia pty ltd - theophylline, quantity: 20.63 mg/ml; ethylenediamine, quantity: 5.477 mg/ml; ethylenediamine - injection, solution - excipient ingredients: water for injections - aminophylline injection bp is indicated for the treatment of reversible bronchospasm associated with chronic bronchitis, emphysema, bronchial asthma and chronic obstructive pulmonary disease. it may also be used for paroxysmal dyspnoea associated with left heart failure.

Teicoplanin 200 mg Powder and Solvent for Solution for injection/infusion or oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

teicoplanin 200 mg powder and solvent for solution for injection/infusion or oral solution

noridem enterprises limited - teicoplanin - powder and solvent for solution for injection/infusion - 200 milligram(s) - glycopeptide antibacterials; teicoplanin - glycopeptide antibacterials - it is indicated in adults and in children from birth for the parenteral treatment of the following infections :  complicated skin and soft tissue infections,  bone and joint infections,  hospital acquired pneumonia,  community acquired pneumonia,  complicated urinary tract infections,  infective endocarditis,  peritonitis associated with continuous ambulatory peritoneal dialysis (capd)  bacteraemia that occurs in association with any of the indications listed above.

Teicoplanin 400 mg Powder and Solvent for Solution for injection/infusion or oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

teicoplanin 400 mg powder and solvent for solution for injection/infusion or oral solution

noridem enterprises limited - teicoplanin - powder and solvent for solution for injection/infusion - 400 milligram(s) - glycopeptide antibacterials; teicoplanin - glycopeptide antibacterials - it is indicated in adults and in children from birth for the parenteral treatment of the following infections: complicated skin and soft tissue infections; bone and joint infections; hospital acquired pneumonia; community acquired pneumonia; complicated urinary tract infections; infective endocarditis; peritonitis associated with continuous ambulatory peritoneal dialysis (capd) · bacteraemia that occurs in association with any of the indications listed above; also indicated as an alternative oral treatment for clostridium difficile infection- associated diarrhoea and colitis

Cosmegen dactinomycin (actinomycin D) 0.5mg injection Australia - English - Department of Health (Therapeutic Goods Administration)

cosmegen dactinomycin (actinomycin d) 0.5mg injection

recordati rare diseases australia pty ltd - dactinomycin, quantity: 500 microgram - injection, powder for - excipient ingredients: mannitol - wilm's tumour; rhabdomyosarcoma; carcinoma of the testes and uterus. other neoplasms: actinomycin d given iv or by regional perfusion, either alone or with other antineoplastic compounds or with x-ray therapy in the palliative treatment of ewing's sarcoma and sarcoma botryoides; non-metastatic ewing's carcinoma. actinomyin d and radiation therapy; actinomycin d in various types of sarcoma, carcinoma and adenocarcinoma using isolation-perfusion technique. for full list of indications refer to approved pi document.

MORPHINE SULFATE 30 mg/1 mL MEDSURGE morphine sulfate pentahydrate 30 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 30 mg/1 ml medsurge morphine sulfate pentahydrate 30 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 30 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 10 mg/1 mL MEDSURGE morphine sulfate pentahydrate 10 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 10 mg/1 ml medsurge morphine sulfate pentahydrate 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 2 mg/1 mL MEDSURGE morphine sulfate pentahydrate 2 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 2 mg/1 ml medsurge morphine sulfate pentahydrate 2 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 2 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 15 mg/1 mL MEDSURGE morphine sulfate pentahydrate 15 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 15 mg/1 ml medsurge morphine sulfate pentahydrate 15 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 15 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 5 mg/1 mL MEDSURGE morphine sulfate pentahydrate 5 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 5 mg/1 ml medsurge morphine sulfate pentahydrate 5 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.